Tag: Screening
Eligibility for Lung Cancer Screening Up With 2021 USPSTF Recommendations
Of those newly eligible under 2021 criteria, 2,063,840 were aged 50 to 54 years and 4,020,879 had 20 to 29-pack-year smoking history
Childhood Cancer Survivors Often Not Adherent to Surveillance Tests
Only 13, 6, 53 percent of survivors at increased risk for CRC, breast cancer, cardiomyopathy adherent to surveillance
Blacks Less Likely to Undergo Evaluation for Genetic Testing
Among patients with neurologic conditions, Blacks are less likely than Whites to undergo evaluation for genetic testing
Additional Benefit Seen for Colonoscopy Versus Sigmoidoscopy
In recent study, fewer CRC cases and deaths per 100,000 person-years were observed
Markers of Systemic Inflammation May Aid Diabetes Risk Prediction
Findings seen for high-sensitivity C-reactive protein, monocyte-to-high-density lipoprotein ratio
Fecal Occult Blood Testing Tied to Reduction in Colorectal Cancer Mortality
Findings show 14 percent decreased colorectal cancer mortality over 14 years
USPSTF: Evidence Lacking for Iron Deficiency Screening in Pregnancy
Insufficient evidence found for assessing benefits, harms of screening and iron supplementation for preventing adverse outcomes
Repeat Preeclampsia Testing Not Tied to Better Perinatal Outcomes
No benefit seen for stillbirth, early neonatal death, or neonatal unit admission
Annual Breast Cancer Screening From Ages 40 to 79 Years Is Best Strategy
Annual screening appears to provide the greatest benefit and lowest risk
Multitarget Fecal Immunochemical Test Increases Detection of Advanced Adenoma
mtFIT-based screening could reduce incidence of colorectal cancer by 21 percent and associated mortality by 18 percent
